Speech Pathology Australia Annual Report 2020

Statement of changes in equity For the year ended 31 December 2020

Notes

Retained earnings

Total equity

$

$

Balance at 1 January 2019 Application of AASB 16

2,929,027

2,929,027

13,695

13,695

Restated balance at 1 January 2019 Net surplus/(deficit) for the year

2,942,722

2,942,722

(36,550)

(36,550)

-

-

Other comprehensive income

Total comprehensive income for the year

(36,550)

(36,550)

Balance at 31 December 2019 Net surplus/(deficit) for the year Other comprehensive income

2,906,172

2,906,172

328,104

328,104

-

-

Total comprehensive income for the year

328,104

328,104

Balance at 31 December 2020

3,234,276

3,234,276

This statement should be read in conjunction with the notes to the financial statements.

Statement of cash flows For the year ended 31 December 2020

Notes

2020

2019

$

$

Operating services Receipts from Member Services

7,154,719 (6,158,193)

6,992,230 (6,888,659)

Payments to members, suppliers and employees

Income tax paid Interest received

8,280

(30,692) 119,462 (28,806) 163,535

35,708 (35,198)

Interest paid

Net cash provided by operating activities

1,005,316

18

Investing activities Proceeds from redemption of / (payment for) financial assets

(738,279) (56,908) (795,187)

3,724,287

Purchase of property, plant and equipment

(38,307)

Net cash provided by / (used in) investing activities

3,685,980

Financing activities Repayment of lease liability

(249,169) (249,169)

(188,072) (188,072)

Net cash provided by / (used in) financing activities

Net change in cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year

(39,040)

3,661,443

4,597,607 4,558,567

936,164

4,597,607

7

This statement should be read in conjunction with the notes to the financial statements.

25

2020 ANNUAL REPORT Speech Pathology Australia